Issue Date: July 2, 2012
Qiagen Buys Sequencing Firm
Qiagen, a Hilden, Germany-based maker of sample preparation and assay technologies, has purchased Intelligent Bio-Systems, a privately held maker of genetic-sequencing equipment. Financial details were not disclosed. Founded in 2005, Waltham, Mass.-based IBS holds the license to the sequencing-by-synthesis technology developed by Columbia University scientist Jingyue Ju. Qiagen says the acquisition will help it establish next-generation sequencing technology in clinical research and molecular diagnostics.
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society